Related references
Note: Only part of the references are listed.Thirty-Nine Novel Neurofibromatosis 1 (NF1) Gene Mutations Identified in Slovak Patients
Martina Nemethova et al.
ANNALS OF HUMAN GENETICS (2013)
Mutation Spectrum of NF1 and Clinical Characteristics in 78 Korean Patients With Neurofibromatosis Type 1
Jung Min Ko et al.
PEDIATRIC NEUROLOGY (2013)
Enhancers and silencers: an integrated and simple model for their function
Petros Kolovos et al.
EPIGENETICS & CHROMATIN (2012)
NF1 Microdeletions in Neurofibromatosis Type 1: From Genotype to Phenotype
Eric Pasmant et al.
HUMAN MUTATION (2010)
Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications
Oren N. Gottfried et al.
NEUROSURGICAL FOCUS (2010)
Functional properties and evolutionary splicing constraints on a composite exonic regulatory element of splicing in CFTR exon 12
Ariful Haque et al.
NUCLEIC ACIDS RESEARCH (2010)
The RAS/MAPK syndromes: Novel roles of the RAS pathway in human genetic disorders
Yoko Aoki et al.
HUMAN MUTATION (2008)
Nature and mRNA Effect of 282 Different NF1 Point Mutations: Focus on Splicing Alterations
Eva Pros et al.
HUMAN MUTATION (2008)
RNA landscape of evolution for optimal exon and intron discrimination
Chaolin Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Molecular diagnosis of neurofibromatosis type 1: 2 years experience
Sian Griffiths et al.
FAMILIAL CANCER (2007)
Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5 ' splice-site disruption
K. Wimmer et al.
HUMAN MUTATION (2007)
Hyperactive Ras in developmental disorders and cancer
Suzanne Schubbert et al.
NATURE REVIEWS CANCER (2007)
An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in Exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation
M. Upadhyaya et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Neurofibromin:: a general outlook
A. B. Trovo-Marqui et al.
CLINICAL GENETICS (2006)
Splicing in action: assessing disease causing sequence changes
D Baralle et al.
JOURNAL OF MEDICAL GENETICS (2005)
Silencer elements as possible inhibitors of pseudoexon splicing
M Sironi et al.
NUCLEIC ACIDS RESEARCH (2004)
Systematic identification and analysis of exonic splicing silencers
ZF Wang et al.
CELL (2004)
Computational definition of sequence motifs governing constitutive exon splicing
XHF Zhang et al.
GENES & DEVELOPMENT (2004)
Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1
A Zatkova et al.
HUMAN MUTATION (2004)
NF1 exon 7 skipping and sequence alterations in exonic splice enhancers (ESEs) in a neurofibromatosis 1 patient
P Colapietro et al.
HUMAN GENETICS (2003)
Evaluation of genotype-phenotype correlations in neurofibromatosis type 1
B Castle et al.
JOURNAL OF MEDICAL GENETICS (2003)
Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras
S Yunoue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients -: art. no. e82
E Ars et al.
JOURNAL OF MEDICAL GENETICS (2003)
NF1 tumor suppressor gene function: Narrowing the GAP
K Cichowski et al.
CELL (2001)
Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases
BJ Blencowe
TRENDS IN BIOCHEMICAL SCIENCES (2000)
Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1
E Ars et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
